MBX: the cashflow

MyFinsight

For the quarter ending 2025-09-30, MBX had $183,344K increase in cash & cash equivalents over the period. -$21,935K in free cash flow.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net loss	-21,618	-43,291
Stock-based compensation expense	2,245	3,776
Non cash operating lease expense	32	69
Depreciation expense	-	138
Accretion and amortization of marketable securities, net	734	2,322
Depreciation expense	50	138
Prepaid expenses and other current assets	1,545	-853
Accounts payable	-2,042	447
Accrued expenses	2,038	305
Operating lease right-of-use asset	-65	566
Operating lease liability	-27	479
Net cash used in operating activities	-21,536	-40,112
Purchases of property and equipment	399	737
Purchases of marketable securities	46,395	106,323
Maturities of marketable securities	61,350	130,272
Call redemptions of marketable securities	2,500	6,000
Net cash provided by (used in) investing activities	17,056	29,212
Proceeds from public offering, net of underwriting discounts and commissions	187,948	-
Aggregate gross proceeds from underwritten public offering	0	-
Proceeds from exercise of stock options	130	1,330
Payments related to offering costs	254	0
Proceeds from the issuance of series c convertible preferred stock-Series CConvertible Preferred Stock	0	-
Preferred stock issuance costs	0	-
Net cash provided by financing activities	187,824	1,330
Net increase in cash and cash equivalents	183,344	-9,570
Cash and cash equivalents at beginning of period	49,351	-
Cash and cash equivalents at end of period	223,125	-

Unit: Thousand (K) dollars